Dianthus Therapeutics, Inc. /DE/ (DNTH) Operating cash flow 2016–2025
Dianthus Therapeutics, Inc. /DE/ (DNTH) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$129.1MFY2025 · since FY2016: -$6.5M → -$129.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$129.1M | -65.1% |
| FY2024 | -$78.2M | -112.1% |
| FY2023 | -$36.9M | -26.8% |
| FY2022 | -$29.1M | +51.2% |
| FY2021 | -$59.5M | +7.0% |
| FY2020 | -$64.0M | -12.1% |
| FY2019 | -$57.1M | -36.3% |
| FY2018 | -$41.9M | -88.1% |
| FY2017 | -$22.3M | -241.0% |
| FY2016 | -$6.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DNTH financial trends
DNTH RevenueDNTH Net incomeDNTH Net marginDNTH Gross profitDNTH Gross marginDNTH Operating incomeDNTH Operating marginDNTH Free cash flowDNTH Capital expendituresDNTH Return on equityDNTH Stock buybacksDNTH Dividends paidDNTH Total assetsDNTH Total liabilitiesDNTH Shareholders’ equityDNTH overview →